Kom op tegen Kanker emphasises the complementary nature of its funding. We only award grants for clinical cancer research with a potentially high patient benefit but for which no or insufficient funding is being made available by government, industry and/or other funders.
Budget: 6.000.000 euro
Deadline: 17 January 2025 (abstract); 09 July 2025 (full proposal)